Michael Porter: Everything you need to know

Michael Porter

#17 SF

Brooklyn Nets

Status

OUT - Hamstring - Strain Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

17.3

6.5

1.6

0.5

0.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	52	52	32.5	24.2	7.1	3.0	0.3	1.1	2.3	12	3.4	9.3	36.3%	5.2	9.1	56.7%	8.5	18.4	46.3%	3.8	4.4	85.9%	1.3	5.7	2.2	1.3	-205	59.5%
2024-25	77	77	33.7	18.2	7.0	2.1	0.5	0.6	1.4	15	2.5	6.4	39.5%	4.4	7.3	59.9%	6.9	13.6	50.4%	1.9	2.5	76.8%	1.8	5.2	2.0	1.6	+265	61.7%
2023-24	81	81	31.7	16.7	7.0	1.5	0.7	0.5	1.1	14	2.7	6.8	39.7%	3.7	6.5	57.5%	6.4	13.3	48.4%	1.1	1.4	83.6%	1.3	5.7	1.8	1.3	+470	60.1%
2022-23	62	62	29.0	17.4	5.5	1.0	0.5	0.6	1.1	3	3.0	7.3	41.4%	3.4	5.9	57.9%	6.4	13.2	48.7%	1.5	1.9	80.0%	1.0	4.5	1.9	1.0	+418	62.1%
2021-22	9	9	29.4	9.9	6.6	1.9	0.2	1.1	1.3	1	1.1	5.3	20.8%	3.0	6.1	49.1%	4.1	11.4	35.9%	0.6	1.0	55.6%	1.0	5.6	1.8	1.4	+58	41.6%
2020-21	61	54	31.3	19.0	7.3	1.1	0.9	0.7	1.3	15	2.8	6.3	44.5%	4.5	7.1	62.8%	7.3	13.4	54.2%	1.7	2.2	79.1%	1.5	5.8	2.1	0.9	+360	66.3%
2019-20	55	8	16.4	9.3	4.7	0.8	0.5	0.5	0.9	9	1.1	2.7	42.2%	2.4	4.3	56.4%	3.5	7.0	50.9%	1.1	1.3	83.3%	1.2	3.5	1.8	0.9	+21	61.7%
Career	397	343	29.5	17.3	6.5	1.6	0.5	0.7	1.3	69	2.6	6.4	39.8%	3.9	6.7	58.5%	6.5	13.1	49.3%	1.8	2.2	81.2%	1.4	5.1	2.0	1.2	+1387	61.4%

Career Averages

PTS

REB

AST

BLK

STL

13.0

6.8

1.1

0.5

0.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	14	14	31.1	9.1	5.5	0.6	0.4	0.6	0.9	1	1.7	5.0	34.3%	1.6	3.6	46.0%	3.4	8.6	39.2%	0.7	1.0	71.4%	1.0	4.5	1.9	0.7	-21	50.7%
2023-24	12	12	36.9	15.8	6.8	1.1	0.8	0.9	1.5	2	2.8	6.8	40.7%	2.9	5.4	53.8%	5.7	12.2	46.6%	1.7	2.2	76.9%	0.7	6.2	2.3	0.7	-9	60.0%
2022-23	20	20	32.7	13.4	8.1	1.6	0.6	0.5	0.5	8	2.3	6.6	35.1%	2.7	5.2	51.5%	5.0	11.7	42.3%	1.2	1.5	79.3%	1.0	7.1	2.1	3.4	+150	54.1%
2020-21	10	10	33.2	17.4	6.2	1.3	0.3	1.1	1.6	1	2.9	7.3	39.7%	3.5	6.2	56.5%	6.4	13.5	47.4%	1.7	2.1	81.0%	1.2	5.0	3.1	0.8	-32	60.3%
2019-20	19	3	23.7	11.4	6.7	0.8	0.3	0.7	1.3	2	1.8	4.7	38.2%	2.3	3.9	58.7%	4.1	8.6	47.6%	1.4	1.8	74.3%	1.1	5.6	2.3	0.6	+54	60.2%
Career	75	59	30.9	13.0	6.8	1.1	0.5	0.7	1.1	14	2.2	5.9	37.4%	2.5	4.7	53.5%	4.7	10.7	44.6%	1.3	1.7	76.8%	1.0	5.8	2.3	1.0	+142	57.0%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/12	PHX	W 111-109	24	15	4	0	0	2	3	7	3	42.9%	4	3	75.0%	11	6	54.5%	1	0	0.0%	1	3	0.0	-6	2	11	65.6%
10/10	PHX	L 132-127	20	13	4	2	0	0	3	3	2	66.7%	5	2	40.0%	8	4	50.0%	3	3	100.0%	1	3	0.7	+3	1	14	69.7%
10/4	HAP	W 123-88	16	13	5	4	0	1	0	5	2	40.0%	4	3	75.0%	9	5	55.6%	3	1	33.3%	1	4	0.0	+14	2	17	63.0%
Preseason Totals			20.3	13.7	4.3	2.0	0.0	1.0	2.0	5.0	2.3	46.7%	4.3	2.7	61.5%	9.3	5.0	53.6%	2.3	1.3	57.1%	1.0	3.3	1.0	+11	1.7	16.0	66.0%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
3/10	DET	L 138-100	22	19	2	1	0	1	3	6	1	16.7%	8	6	75.0%	14	7	50.0%	4	4	100.0%	1	1	0.3	-31	4	12	60.3%
3/7	DET	W 107-105	39	30	13	1	1	2	2	12	3	25.0%	13	7	53.8%	25	10	40.0%	7	7	100.0%	2	11	0.5	+13	2	36	53.4%
3/5	MIA	L 126-110	35	27	13	3	1	2	3	18	7	38.9%	6	2	33.3%	24	9	37.5%	3	2	66.7%	3	10	1.0	+2	3	25	53.3%
3/3	MIA	L 124-98	26	9	3	3	0	0	0	9	0	0.0%	8	3	37.5%	17	3	17.6%	4	3	75.0%	1	2	0.0	-18	2	2	24.0%
3/1	CLE	L 106-102	30	26	5	1	0	3	2	8	5	62.5%	9	5	55.6%	17	10	58.8%	2	1	50.0%	1	4	0.5	-8	3	21	72.7%
2/27	BOS	L 148-111	25	18	2	2	0	2	1	4	2	50.0%	8	4	50.0%	12	6	50.0%	5	4	80.0%	0	2	2.0	-23	2	18	63.4%
2/26	SAS	L 126-110	30	25	14	1	0	0	6	9	3	33.3%	13	6	46.2%	22	9	40.9%	4	4	100.0%	3	11	0.2	-7	1	22	52.6%
2/24	DAL	L 123-114	32	26	0	3	0	0	1	6	2	33.3%	10	7	70.0%	16	9	56.3%	6	6	100.0%	0	0	3.0	-4	2	22	69.7%
2/22	ATL	L 115-104	34	18	7	6	0	0	0	8	1	12.5%	11	7	63.6%	19	8	42.1%	1	1	100.0%	2	5	0.0	-15	3	18	46.3%
2/20	OKC	L 105-86	37	22	9	5	0	2	2	9	1	11.1%	7	5	71.4%	16	6	37.5%	11	9	81.8%	3	6	2.5	-3	3	27	52.8%
2/19	CLE	L 112-84	20	14	5	2	1	0	0	6	1	16.7%	7	4	57.1%	13	5	38.5%	3	3	100.0%	0	5	0.0	-23	2	11	48.9%
2/7	WAS	W 127-113	30	23	6	3	0	1	3	10	3	30.0%	6	5	83.3%	16	8	50.0%	4	4	100.0%	2	4	1.0	-8	3	20	64.8%
2/5	ORL	L 118-98	32	9	2	2	0	1	2	7	2	28.6%	6	0	0.0%	13	2	15.4%	3	3	100.0%	0	2	1.0	-23	3	5	31.4%
2/3	LAL	L 125-109	32	21	10	3	0	1	3	9	0	0.0%	9	7	77.8%	18	7	38.9%	9	7	77.8%	1	9	1.0	-18	3	22	47.8%
1/29	DEN	L 107-103	37	38	10	3	2	2	1	15	7	46.7%	13	6	46.2%	28	13	46.4%	5	5	100.0%	2	8	3.0	+12	3	38	62.9%
1/27	PHX	L 106-102	36	36	5	3	0	3	3	10	6	60.0%	14	9	64.3%	24	15	62.5%	1	0	0.0%	2	3	1.0	+0	3	30	73.6%
1/25	LAC	L 126-89	21	9	2	4	0	0	1	4	0	0.0%	7	3	42.9%	11	3	27.3%	3	3	100.0%	0	2	4.0	-25	2	6	36.5%
1/23	BOS	L 130-126	41	30	8	4	1	0	2	12	4	33.3%	7	5	71.4%	19	9	47.4%	9	8	88.9%	1	7	2.0	+0	3	35	65.3%
1/21	NYK	L 120-66	25	12	6	1	0	0	2	9	3	33.3%	5	1	20.0%	14	4	28.6%	1	1	100.0%	1	5	0.5	-26	0	10	41.6%
1/19	PHX	L 126-117	36	23	6	4	0	2	3	10	2	20.0%	13	8	61.5%	23	10	43.5%	1	1	100.0%	2	4	1.3	-5	3	17	49.1%
1/16	CHI	W 112-109	32	26	7	1	0	1	3	10	5	50.0%	7	4	57.1%	17	9	52.9%	3	3	100.0%	1	6	0.3	+4	1	25	71.0%
1/14	NOP	L 116-113	31	20	7	1	0	0	2	12	4	33.3%	8	3	37.5%	20	7	35.0%	2	2	100.0%	3	4	0.5	-2	2	12	47.9%
1/12	DAL	L 113-105	33	28	9	3	0	1	6	10	6	60.0%	7	3	42.9%	17	9	52.9%	4	4	100.0%	1	8	0.5	-3	1	30	74.6%
1/9	LAC	L 121-105	33	18	5	6	1	4	2	9	0	0.0%	11	7	63.6%	20	7	35.0%	4	4	100.0%	0	5	3.0	-9	1	20	41.4%
1/7	ORL	L 104-103	38	34	5	1	0	3	5	18	8	44.4%	6	4	66.7%	24	12	50.0%	2	2	100.0%	0	5	0.2	+1	2	26	68.3%
1/4	DEN	W 127-115	32	27	11	5	1	0	4	6	2	33.3%	11	6	54.5%	17	8	47.1%	9	9	100.0%	4	7	1.3	+22	3	34	64.4%
12/29	GSW	L 120-107	36	27	9	5	0	3	2	9	5	55.6%	9	5	55.6%	18	10	55.6%	4	2	50.0%	3	6	2.5	+3	0	38	68.3%
12/27	MIN	W 123-107	33	27	10	4	0	0	3	8	4	50.0%	8	5	62.5%	16	9	56.3%	5	5	100.0%	2	8	1.3	-1	2	33	74.2%
12/23	PHI	W 114-106	33	28	5	1	0	2	3	12	5	41.7%	8	4	50.0%	20	9	45.0%	7	5	71.4%	1	4	0.3	+7	4	21	60.7%
12/21	TOR	W 96-81	36	24	11	5	0	1	3	8	4	50.0%	10	5	50.0%	18	9	50.0%	2	2	100.0%	1	10	1.7	+26	3	29	63.6%
12/18	MIA	L 106-95	33	28	6	3	0	0	1	14	5	35.7%	10	5	50.0%	24	10	41.7%	3	3	100.0%	2	4	3.0	-7	1	22	55.3%
12/14	MIL	W 127-82	26	12	6	5	0	0	3	7	2	28.6%	4	2	50.0%	11	4	36.4%	3	2	66.7%	0	6	1.7	+13	1	14	48.7%
12/12	DAL	L 119-111	34	34	4	3	0	0	4	10	6	60.0%	10	6	60.0%	20	12	60.0%	5	4	80.0%	1	3	0.8	-7	3	33	76.6%
12/6	NOP	W 119-101	33	35	9	3	1	2	2	10	5	50.0%	13	9	69.2%	23	14	60.9%	2	2	100.0%	2	7	1.5	+31	1	40	73.3%
12/3	CHI	W 113-103	33	33	10	5	1	2	3	12	5	41.7%	8	5	62.5%	20	10	50.0%	10	8	80.0%	1	9	1.7	+3	4	38	67.6%
12/1	CHA	W 116-103	36	35	7	4	0	2	2	11	7	63.6%	13	6	46.2%	24	13	54.2%	4	2	50.0%	2	5	2.0	+18	3	33	67.9%
11/24	NYK	L 113-100	27	16	4	0	0	0	2	9	1	11.1%	6	5	83.3%	15	6	40.0%	5	3	60.0%	2	2	0.0	-21	1	9	46.5%
11/23	TOR	L 119-109	32	25	6	4	1	1	1	9	4	44.4%	9	5	55.6%	18	9	50.0%	3	3	100.0%	1	5	4.0	-6	3	24	64.7%
11/21	BOS	W 113-105	36	33	8	2	0	0	2	6	4	66.7%	15	9	60.0%	21	13	61.9%	5	3	60.0%	0	8	1.0	+13	1	36	71.1%
11/18	BOS	L 113-99	33	25	6	2	0	3	1	8	4	50.0%	8	4	50.0%	16	8	50.0%	5	5	100.0%	2	4	2.0	-9	1	30	68.7%
11/16	WAS	W 129-106	33	34	9	7	0	0	2	8	3	37.5%	10	8	80.0%	18	11	61.1%	10	9	90.0%	0	9	3.5	+17	2	43	75.9%
11/14	ORL	L 105-98	36	24	11	7	0	1	0	11	3	27.3%	12	7	58.3%	23	10	43.5%	1	1	100.0%	1	10	0.0	-7	2	29	51.2%
11/11	TOR	L 119-109	35	21	6	3	1	0	3	6	1	16.7%	8	4	50.0%	14	5	35.7%	10	10	100.0%	1	5	1.0	-2	3	21	57.1%
11/9	NYK	L 134-98	25	25	4	0	0	1	2	9	4	44.4%	9	5	55.6%	18	9	50.0%	4	3	75.0%	1	3	0.0	-22	3	17	63.3%
11/7	DET	L 125-107	31	28	5	2	0	1	4	10	5	50.0%	7	3	42.9%	17	8	47.1%	7	7	100.0%	1	4	0.5	-11	1	26	69.7%
11/5	IND	W 112-103	35	32	11	3	0	1	5	11	4	36.4%	9	6	66.7%	20	10	50.0%	11	8	72.7%	2	9	0.6	+2	4	30	64.4%
11/2	PHI	L 129-105	31	17	17	2	0	1	3	12	1	8.3%	11	6	54.5%	23	7	30.4%	2	2	100.0%	3	14	0.7	-6	2	18	35.6%
10/29	ATL	L 117-112	32	32	9	2	1	0	4	9	4	44.4%	11	8	72.7%	20	12	60.0%	4	4	100.0%	2	7	0.5	-3	1	31	73.5%
10/27	HOU	L 137-109	27	18	4	2	0	0	3	4	2	50.0%	9	6	66.7%	13	8	61.5%	0	0	0.0%	1	3	0.7	-13	3	14	69.2%
10/26	SAS	L 118-107	37	15	6	4	0	2	0	9	3	33.3%	6	2	33.3%	15	5	33.3%	3	2	66.7%	0	6	0.0	-6	2	17	46.0%
10/24	CLE	L 131-124	36	31	8	3	0	1	2	10	5	50.0%	12	8	66.7%	22	13	59.1%	0	0	0.0%	0	8	1.5	-1	3	28	70.5%
10/22	CHA	L 136-117	25	12	4	5	0	0	0	7	2	28.6%	8	3	37.5%	15	5	33.3%	2	0	0.0%	1	3	0.0	-19	2	7	37.8%
Regular Season Totals			32.5	24.2	7.1	3.0	0.3	1.1	2.3	9.3	3.4	36.3%	9.1	5.2	56.7%	18.4	8.5	46.3%	4.4	3.8	85.9%	1.3	5.7	1.3	-205	2.2	26.3	59.5%

Michael Porter: Breaking News

Porter (hamstring) has been ruled out for the remainder of the 2025-26 season, Erik Slater of ClutchPoints.com reports. The Nets are sitting on a record of 18-58, and with just six games remaining on the schedule, it's not surprising to see Porter get shut down. The 27-year-old forward hit career highs across the board in his first season with the Nets, contributing top-30 value behind averages of 24.2 points, 7.1 rebounds, 3.0 assists, 3.4 triples and 1.1 steals per game on 46/36/86 shooting splits in 52 regular-season appearances.

An MRI confirmed a left hamstring strain for Porter, and he will be re-evaluated in 2-to-3 weeks. In three weeks from today's date, the Nets will have only three games remaining on their schedule, so there's a decent chance we won't see Porter in uniform again this season. Danny Wolf, Josh Minott and Ziaire Williams (foot) will likely help fill the void while Porter is out.

Porter (ankle, hamstring) is out for Wednesday's game against the Thunder. Porter is missing a fourth consecutive contest due to ankle and hamstring injuries. The star forward's absence should free up more playing time for Danny Wolf and Ziaire Williams in the frontcourt Wednesday.